NOTICE: Many events listed here have been canceled or postponed due to the Covid-19 emergency. It is best to call ahead or check with organizer's websites to verify the status of any local event.

Change Location × Boston

    Recent Locations

      TCR-based Therapies Summit in Boston


      • TCR-based Therapies Summit Photo #1
      1 of 1
      April 22, 2020

      Wednesday   9:00 AM - 5:00 PM (daily until April 22, 2020)

      200 Stuart Street
      Boston, Massachusetts 02116

      Map
      Performers:
      • No Performers Listed
      EVENT DETAILS
      TCR-based Therapies Summit

      The only dedicated end-to-end, industry led TCR therapy summit is a unique opportunity to delve into the details of TCR development. This technical meeting is a rare opportunity to learn from 20+ industry experts from Ziopharm, Immatics US, TScan Therapeutics and many more. Gain insights on their various approaches and be the first to hear cutting-edge data from this fast-paced industry.

      A 23.1% growth rate since 2009 spells progress in the TCR-Based therapies space. This dedicated meeting brings you the industry leaders pushing the bounds of T Cell therapies. With a building number of Phase 1 and Phase 2 trials on the horizon, stay ahead of this booming field at the TCR-based therapies summit.

      Covering the most exciting developments and promising clinical data, the TCR-based Therapies Summit will propel your research ahead in 2020 with optimized target identification, supercharged T-cell modifications and insights to the future of manufacturing. For leaders in the TCR space, this is not a meeting to be missed!

      https://tcr-therapies-summit.com/

      April 20-22, 2020

      Contact:
      info@hansonwade.com
      +1 617 455 4188

      Speakers: Laurence Cooper, Chief Executive Officer, Ziopharm Oncology, Robert Hofmeister, Chief Scientific Officer, TCR2, Cheng Liu, Chief Executive Officer, Eureka Therapeutics, Gavin MacBeath, Chief Scientific Officer, TScan Therapeutics, David Scheinberg, Chairman, Molecular Pharmacology, MSKCC, Dolores Schendel, Chief Executive Officer, Medigene, Pete Smith, Chief Executive Officer, Affinity Bio, Steffen Walter, Chief Scientific Officer, Immatics US

      Cost: Payment required - Conference Only - Earlybirds Available: USD 2999.0, Conference + 1 Workshop (A or B) - Earlybirds Available: USD 3598.0, Conference + 2 Workshops (A And B) - Earlybirds Available: USD 4197.0, Workshops (Individual): USD 599.0

      Categories: Conferences & Tradeshows

      This event repeats daily until April 22, 2020: Apr 20, Apr 21, Apr 22

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.

      Hotels and Airbnbs near TCR-based Therapies Summit. Book your stay now!